<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32673563</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>G<sub>4</sub>C<sub>2</sub> Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD.</ArticleTitle><Pagination><StartPage>1124</StartPage><EndPage>1140.e11</EndPage><MedlinePgn>1124-1140.e11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2020.06.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(20)30481-5</ELocationID><Abstract><AbstractText>Through mechanisms that remain poorly defined, defects in nucleocytoplasmic transport and accumulations of specific nuclear-pore-complex-associated proteins have been reported in multiple neurodegenerative diseases, including C9orf72 Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (ALS/FTD). Using super-resolution structured illumination microscopy, we have explored the mechanism by which nucleoporins are altered in nuclei isolated from C9orf72 induced pluripotent stem-cell-derived neurons (iPSNs). Of the 23 nucleoporins evaluated, we observed a reduction in a subset of 8, including key components of the nuclear pore complex scaffold and the transmembrane nucleoporin POM121. Reduction in POM121 appears to initiate a decrease in the expression of seven additional nucleoporins, ultimately affecting the localization of Ran GTPase and subsequent cellular toxicity in C9orf72 iPSNs. Collectively, our data suggest that the expression of expanded C9orf72 ALS/FTD repeat RNA alone affects nuclear POM121 expression in the initiation of a pathological cascade affecting nucleoporin levels within neuronal nuclei and ultimately downstream neuronal survival.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coyne</LastName><ForeName>Alyssa N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaepfel</LastName><ForeName>Benjamin L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Biochemistry, Cellular, and Molecular Biology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Lindsey</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitchman</LastName><ForeName>Boris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salzberg</LastName><ForeName>Yuval</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>En-Ching</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Bioengineering Graduate Program, University of California San Diego College of Engineering, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowen</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trost</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aigner</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigo</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ionis Pharmaceuticals, Carlsbad, CA 92010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Gene W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA 92037, USA; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harel</LastName><ForeName>Amnon</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svendsen</LastName><ForeName>Clive N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>The Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sareen</LastName><ForeName>Dhruv</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothstein</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: jrothstein@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS094239</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062171</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS085207</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS122236</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG025688</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS084974</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS099114</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS091046</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 NS104273</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD020007</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028861">Nuclear Pore Complex Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C094157">POM121 protein, human</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058953" MajorTopicYN="N">Neural Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022022" MajorTopicYN="N">Nuclear Pore</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028861" MajorTopicYN="N">Nuclear Pore Complex Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">POM121</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">nuclear pore complex</Keyword></KeywordList><CoiStatement>Declarations of Interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32673563</ArticleId><ArticleId IdType="mid">NIHMS1608903</ArticleId><ArticleId IdType="pmc">PMC8077944</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2020.06.027</ArticleId><ArticleId IdType="pii">S0896-6273(20)30481-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ababneh NA, Scaber J, Flynn R, Douglas A, Barbagallo P, Candalija A, Turner MR, Sims D, Dafinca R, Cowley SA, et al. (2020). Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair. Human molecular genetics.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399532</ArticleId><ArticleId IdType="pubmed">32504093</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonin W, Franz C, Haselmann U, Antony C, and Mattaj IW (2005). The integral membrane nucleoporin pom121 functionally links nuclear pore complex assembly and nuclear envelope formation. Molecular cell 17, 83&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">15629719</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, and Isaacs AM (2018). C9orf72-mediated ALS and FTD: multiple pathways to disease. Nature reviews Neurology.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M, and Hurt E (2017). The nuclear pore complex: understanding its function through structural insight. Nature reviews Molecular cell biology 18, 73&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">27999437</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, Wang S, Zhang Z, Morgens DW, Hayes LR, Lee S, Portz B, Xie Y, Nguyen BV, Haney MS, et al. (2019). CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation. Neuron 104, 885&#x2013;898.e888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM, Castanedes-Casey M, Kurti A, Stankowski JN, Disney MD, et al. (2019). Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Molecular neurodegeneration 14, 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, Sayegh M, Donlin-Asp PG, Chen YH, Duong DM, et al. (2018). TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nature neuroscience 21, 228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, and Schuh M (2017). A Method for the Acute and Rapid Degradation of Endogenous Proteins. Cell 171, 1692&#x2013;1706.e1618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5733393</ArticleId><ArticleId IdType="pubmed">29153837</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C, and Petrucelli L (2019). Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS. Neuron 101, 1057&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo MA, Raices M, Panowski SH, and Hetzer MW (2009). Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell 136, 284&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2805151</ArticleId><ArticleId IdType="pubmed">19167330</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Finch NA, Wang X, Gendron TF, Bieniek KF, Heckman MG, Vasilevich A, Murray ME, Rousseau L, Weesner R, et al. (2017). In-depth clinicopathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers. Acta neuropathologica 134, 255&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5508036</ArticleId><ArticleId IdType="pubmed">28508101</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, et al. (2013). RnA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucet CM, Talamas JA, and Hetzer MW (2010). Cell cycle-dependent differences in nuclear pore complex assembly in metazoa. Cell 141, 1030&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887351</ArticleId><ArticleId IdType="pubmed">20550937</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ, Dujardin S, Amaral AS, et al. (2018). Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer&#x2019;s Disease. Neuron 99, 925&#x2013;940.e927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240334</ArticleId><ArticleId IdType="pubmed">30189209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Kapogiannis D, Huey ED, and Momeni P (2011). FTD and ALS: a tale of two diseases. Current Alzheimer research 8, 273&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>Fichtman B, Harel T, Biran N, Zagairy F, Applegate CD, Salzberg Y, Gilboa T, Salah S, Shaag A, Simanovsky N, et al. (2019). Pathogenic Variants in NUP214 Cause &#x201c;Plugged&#x201d; Nuclear Pore Channels and Acute Febrile Encephalopathy. American journal of human genetics.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612515</ArticleId><ArticleId IdType="pubmed">31178128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fichtman B, Shaulov L, and Harel A (2014). Imaging metazoan nuclear pore complexes by field emission scanning electron microscopy. Methods in cell biology 122, 41&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">24857724</ArticleId></ArticleIdList></Reference><Reference><Citation>Franks TM, Benner C, Narvaiza I, Marchetto MC, Young JM, Malik HS, Gage FH, and Hetzer MW (2016). Evolution of a transcriptional regulator from a transmembrane nucleoporin. Genes &amp; development 30, 1155&#x2013;1171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888837</ArticleId><ArticleId IdType="pubmed">27198230</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee KH, Badders N, Valentine M, Miller BL, Wong PC, et al. (2015). GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Funakoshi T, Clever M, Watanabe A, and Imamoto N (2011). Localization of Pom121 to the inner nuclear membrane is required for an early step of interphase nuclear pore complex assembly. Molecular biology of the cell 22, 1058&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069009</ArticleId><ArticleId IdType="pubmed">21289085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Chillon-Marinas C, Goginashvili A, Atwal RS, Artates JW, Tabet R, Wheeler VC, Bang AG, Cleveland DW, and Lagier-Tourenne C (2017). Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport. Neuron 94, 48&#x2013;57.e44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5479704</ArticleId><ArticleId IdType="pubmed">28384474</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Chew J, Stankowski JN, Hayes LR, Zhang YJ, Prudencio M, Carlomagno Y, Daughrity LM, Jansen-West K, Perkerson EA, et al. (2017). Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Science translational medicine 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, and Tsuiji H (2016). There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS. Brain research 1647, 19&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003651</ArticleId><ArticleId IdType="pubmed">27059391</ArticleId></ArticleIdList></Reference><Reference><Citation>Grima JC, Daigle JG, Arbez N, Cunningham KC, Zhang K, Ochaba J, Geater C, Morozko E, Stocksdale J, Glatzer JC, et al. (2017). Mutant Huntingtin Disrupts the Nuclear Pore Complex. Neuron 94, 93&#x2013;107.e106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5595097</ArticleId><ArticleId IdType="pubmed">28384479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampoelz B, Andres-Pons A, Kastritis P, and Beck M (2019). Structure and Assembly of the Nuclear Pore Complex. Annual review of biophysics.</Citation><ArticleIdList><ArticleId IdType="pubmed">30943044</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LR, Duan L, Bowen K, Kalab P, and Rothstein JD (2020). C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. eLife 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetzer MW (2010). The role of the nuclear pore complex in aging of post-mitotic cells. Aging 2, 74&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2850141</ArticleId><ArticleId IdType="pubmed">20354266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho R, Sances S, Gowing G, Amoroso MW, O&#x2019;Rourke JG, Sahabian A, Wichterle H, Baloh RH, Sareen D, and Svendsen CN (2016). ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks. Nature neuroscience 19, 1256&#x2013;1267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003654</ArticleId><ArticleId IdType="pubmed">27428653</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S, and Dormann D (2019). Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence? Seminars in cell &amp; developmental biology.</Citation><ArticleIdList><ArticleId IdType="pubmed">31152789</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB, Paul JW 3rd, Sun S, Herdy JR, Bieri G, et al. (2015). Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nature neuroscience 18, 1226&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SJ, Fernandez-Martinez J, Nudelman I, Shi Y, Zhang W, Raveh B, Herricks T, Slaughter BD, Hogan JA, Upla P, et al. (2018). Integrative structure and functional anatomy of a nuclear pore complex. Nature 555, 475&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6022767</ArticleId><ArticleId IdType="pubmed">29539637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita Y, Kalir T, Dottino P, and Kohtz DS (2012). Nuclear distributions of NUP62 and NUP214 suggest architectural diversity and spatial patterning among nuclear pore complexes. PloS one 7, e36137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338603</ArticleId><ArticleId IdType="pubmed">22558357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, et al. (2013). Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proceedings of the National Academy of Sciences of the United States of America 110, E4530&#x2013;4539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ, Mitrea DM, Sarkar M, Freibaum BD, Cika J, Coughlin M, Messing J, Molliex A, et al. (2016). C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell 167, 774&#x2013;788.e717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Goryaynov A, and Yang W (2016). The selective permeability barrier in the nuclear pore complex. Nucleus (Austin, Tex) 7, 430&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120597</ArticleId><ArticleId IdType="pubmed">27673359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DH, and Hoelz A (2019). The Structure of the Nuclear Pore Complex (An Update). Annual review of biochemistry.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588426</ArticleId><ArticleId IdType="pubmed">30883195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, and Cleveland DW (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglione M, and Sigrist SJ (2013). Seeing the forest tree by tree: super-resolution light microscopy meets the neurosciences. Nature neuroscience 16, 790&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">23799471</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchior F (2001). Ran GTPase cycle: oOne mechanism -- two functions. Current biology : CB 11, R257&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">11413013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gronke S, Niccoli T, Ridler CE, Clayton EL, Devoy A, Moens T, Norona FE, Woollacott IOC, Pietrzyk J, et al. (2014). C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science (New York, NY) 345, 1192&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutter CA, Bubenik JL, Oliveira R, Ivankovic F, Sznajder &#x141;,J, Kidd BM, Pinto BS, Otero BA, Carter HA, Vitriol EA, et al. (2019). Cell-type-specific dysregulation of RNA alternative splicing in short tandem repeat mouse knockin models of myotonic dystrophy. Genes &amp; development 33, 1635&#x2013;1640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942047</ArticleId><ArticleId IdType="pubmed">31624084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ori A, Banterle N, Iskar M, Andres-Pons A, Escher C, Khanh Bui H, Sparks L, Solis-Mezarino V, Rinner O, Bork P, et al. (2013). Cell type-specific nuclear pores: a case in point for context-dependent stoichiometry of molecular machines. Molecular systems biology 9, 648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3619942</ArticleId><ArticleId IdType="pubmed">23511206</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne RJ, and Thornton CA (2008). Cell-free cloning of highly expanded CTG repeats by amplification of dimerized expanded repeats. Nucleic acids research 36, e24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2275075</ArticleId><ArticleId IdType="pubmed">18263610</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka S, and Ellenberg J (2018). Mechanisms of nuclear pore complex assembly - two different ways of building one molecular machine. FEBS letters 592, 475&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6220763</ArticleId><ArticleId IdType="pubmed">29119545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual-Garcia P, and Capelson M (2019). Nuclear pores in genome architecture and enhancer function. Current opinion in cell biology 58, 126&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347242</ArticleId><ArticleId IdType="pubmed">31063899</ArticleId></ArticleIdList></Reference><Reference><Citation>Popken P, Ghavami A, Onck PR, Poolman B, and Veenhoff LM (2015). Size-dependent leak of soluble and membrane proteins through the yeast nuclear pore complex. Molecular biology of the cell 26, 1386&#x2013;1394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4454183</ArticleId><ArticleId IdType="pubmed">25631821</ArticleId></ArticleIdList></Reference><Reference><Citation>Raices M, and D&#x2019;Angelo MA (2012). Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions. Nature reviews Molecular cell biology 13, 687&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">23090414</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajoo S, Vallotton P, Onischenko E, and Weis K (2018). Stoichiometry and compositional plasticity of the yeast nuclear pore complex revealed by quantitative fluorescence microscopy. Proceedings of the National Academy of Sciences of the United States of America 115, E3969&#x2013;e3977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5924907</ArticleId><ArticleId IdType="pubmed">29632211</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S, Bruijn LI, Chandran S, Eggan K, Ho R, Klim JR, Livesey MR, Lowry E, Macklis JD, Rushton D, et al. (2016). Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nature neuroscience 19, 542&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5015775</ArticleId><ArticleId IdType="pubmed">27021939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O&#x2019;Rourke JG, Meera P, Muhammad AK, Grant S, Simpkinson M, Bell S, Carmona S, Ornelas L, Sahabian A, et al. (2013). Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Science translational medicine 5, 208ra149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Savas JN, Toyama BH, Xu T, Yates JR 3rd, and Hetzer MW (2012). Extremely long-lived nuclear pore proteins in the rat brain. Science (New York, NY) 335, 942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3296478</ArticleId><ArticleId IdType="pubmed">22300851</ArticleId></ArticleIdList></Reference><Reference><Citation>Schermelleh L, Carlton PM, Haase S, Shao L, Winoto L, Kner P, Burke B, Cardoso MC, Agard DA, Gustafsson MG, et al. (2008). Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy. Science (New York, NY) 320, 1332&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916659</ArticleId><ArticleId IdType="pubmed">18535242</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi KY, Mori E, Nizami ZF, Lin Y, Kato M, Xiang S, Wu LC, Ding M, Yu Y, Gall JG, et al. (2017). Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proceedings of the National Academy of Sciences of the United States of America 114, E1111&#x2013;e1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Talamas JA, and Hetzer MW (2011). POM121 and Sun1 play a role in early steps of interphase NPC assembly. The Journal of cell biology 194, 27&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135402</ArticleId><ArticleId IdType="pubmed">21727197</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr., and Cleveland DW (2016). Decoding ALS: from genes to mechanism. Nature 539, 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Thevathasan JV, Kahnwald M, Cieslinski K, Hoess P, Peneti SK, Reitberger M, Heid D, Kasuba KC, Hoerner SJ, Li Y, et al. (2019). Nuclear pores as versatile reference standards for quantitative superresolution microscopy. Nature methods 16, 1045&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6768092</ArticleId><ArticleId IdType="pubmed">31562488</ArticleId></ArticleIdList></Reference><Reference><Citation>Timney BL, Raveh B, Mironska R, Trivedi JM, Kim SJ, Russel D, Wente SR, Sali A, and Rout MP (2016). Simple rules for passive diffusion through the nuclear pore complex. The Journal of cell biology 215, 57&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5057280</ArticleId><ArticleId IdType="pubmed">27697925</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama BH, Arrojo EDR, Lev-Ram V, Ramachandra R, Deerinck TJ, Lechene C, Ellisman MH, and Hetzer MW (2018). Visualization of long-lived proteins reveals age mosaicism within nuclei of postmitotic cells. The Journal of cell biology.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363465</ArticleId><ArticleId IdType="pubmed">30552100</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama BH, Savas JN, Park SK, Harris MS, Ingolia NT, Yates JR, and Hetzer MW (2013). Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell 154, 971&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788602</ArticleId><ArticleId IdType="pubmed">23993091</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JN, Trujillo A, Pribadi M, Phillips JJ, Gaus SE, Hixson JD, et al. (2016). Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain : a journal of neurology 139, 3202&#x2013;3216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5790143</ArticleId><ArticleId IdType="pubmed">27797809</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, Baumer D, East S, Neal J, Morris HR, Ansorge O, and Blake DJ (2014). Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiology of aging 35, 1779.e1775&#x2013;1779.e1713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y, Lin S, Shneider NA, Monaghan J, Pandey UB, et al. (2014). Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84, 1213&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S, et al. (2015). The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Hu D, Shang Y, and Qi X (2019a). Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. Biochimica et biophysica acta Molecular basis of disease.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6751032</ArticleId><ArticleId IdType="pubmed">30898538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Ebbert MTW, O&#x2019;Raw AD, Yue M, Jansen-West K, Zhang X, Prudencio M, Chew J, Cook CN, et al. (2018). Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nature medicine.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6520050</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Grima JC, Sasaguri H, Jansen-West K, Xu YF, Katzman RB, Gass J, Murray ME, Shinohara M, et al. (2016). C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nature neuroscience 19, 668&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Guo L, Gonzales PK, Gendron TF, Wu Y, Jansen-West K, O&#x2019;Raw AD, Pickles SR, Prudencio M, Carlomagno Y, et al. (2019b). Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science (New York, NY) 363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Liu TW, Madden Z, Yuzwa SA, Murray K, Cecioni S, Zachara N, and Vocadlo DJ (2016). Post-translational O-GlcNAcylation is essential for nuclear pore integrity and maintenance of the pore selectivity filter. Journal of molecular cell biology 8, 2&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4710208</ArticleId><ArticleId IdType="pubmed">26031751</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>